Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMMULOGIC -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (278)	4/1/1999 11:02:00 AM
From: Bosco	Read Replies (1) \| Respond to of 305

Hello Richard - long time. I think the CNTBY value is being traded away as "present value." Not familiar with CNTBY - and its ADR is such an illiquid kind - it is not surprising that the market decided to trade on IMUL's cash alone. Of course, who knows, if CNTBY makes it big in one of its portfolio of novelty drugs, then it should appreciate quickly. Right now though, I doubt we'll see that $1.20 number any time soom While I am in the losing column, I actually do not feel bad. Dr Marr has put up a good fight - and quxiotic that it may sound, and so did I. It may be time to move on best, Bosco